This ETF Could Be a Great Contrarian Artificial Intelligence (AI) Buy Right Now

The iShares Expanded Tech-Software ETF (IGV) is down roughly 18% from its high last fall, while its top three constituents — Microsoft, Palantir Technologies and Oracle — account for about a quarter of the fund. The article argues that despite investor fears that generative AI could displace enterprise software, revenue growth across the ETF's components remains relatively strong and many vendors are integrating AI features that can boost revenue per seat. The author concludes that current sentiment may be overdone, presenting IGV as a discounted route to AI exposure, and discloses long positions in several constituent names.

Analysis

Market structure: The 18% drawdown in IGV (software) has concentrated winners (MSFT, PLTR, ORCL, NVDA) that supply AI infra and platform lock‑in, while perceived incumbents (CRM, INTU, ADBE) trade like they’ll lose customers. Switching costs and multi-year contracts mean market‑share losses will be gradual; expect pricing power to compress 10–30% for mid‑tier SaaS names if multiples re‑rate further. Flow dynamics: continued ETF outflows/sentiment selling can depress prices near term even as revenue growth (mid‑teens YoY for many constituents) persists.

Risk assessment: Tail risks include fast regulatory action (EU AI Act enforcement or US antitrust/FTC moves) and cascade cyber/data breaches that could halt AI adoption; either could erase 30–60% of forward earnings expectations for exposed vendors. Time horizons split: immediate (days–weeks) = sentiment-driven volatility; short (1–6 months) = earnings/feature releases that will either validate AI upsell; long (1–3 years) = structural winner-take-most consolidation. Hidden dependencies: success depends on cloud/semiconductor supply (MSFT/AZURE, NVDA chips) and enterprise procurement cycles.

Trade implications: Favor selective accumulation of cheap exposure (IGV or names with clear AI monetization) over broad shorting of software; use relative-value to short high‑multiple CRM/INTU vs long PLTR/ORCL where AI feature monetization is clearer. Options: use 12–24 month LEAPS to express asymmetric upside on PLTR/ORCL and sell short‑dated calls on MSFT to finance LEAPS. Sector rotation: shift 3–6% from defensive growth into AI infra and durable SaaS with >15% revenue growth and >60% gross margins.

Contrarian angles: Consensus underestimates inertia — enterprises rarely replace best‑of‑breed quickly, so a single AI app replacing suites is low probability over 24 months; the 18% ETF drop likely overstates fundamental risk by ~20–30% given recurring revenue. Historical parallel: 2012–15 SaaS multiple compression reversed once AI/features drove ARPU expansion; unintended consequence: concentration into MSFT/NVDA increases systemic regulatory risk that could be a material downside catalyst.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in IGV within the next 2 weeks; add a second tranche if IGV falls another 5–10%. Set a tactical stop at -12% from entry and a target of +25–40% over 12–24 months if H1/H2 2026 revenue beats continue.
• Initiate concentrated longs: 1–1.5% long PLTR and 2–3% long MSFT now (funds permitting). Use these as core AI exposure — add on 10–15% pullbacks; take profits at +30% or on material multiple expansion after two positive earnings beats.
• Execute a pair trade: long PLTR vs short CRM (1:1 dollar exposure), 0.5–1% of portfolio each leg, horizon 6–12 months. Close if PLTR underperforms CRM by >15% in 90 days or if CRM reports a sustainable AI upsell shifting ARPU >5% higher year-over-year.
• Options: Buy Jan 2028 LEAPS calls on ORCL and PLTR (allocate 0.5–1.0% portfolio to each) to capture asymmetric upside; finance by selling 30–60 day covered or cash‑secured calls on MSFT for premium income. Cut LEAPS if underlying drops >30% or implied volatility rises >40 percentage points vs entry.